<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>IHE.ITI.PCF\clinical codes that indicate HIV - FHIR v4.3.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
<link href="assets/css/ihe.css" rel="stylesheet"/>
<link href="assets/css/nonum.css" rel="stylesheet"/>
<script type="text/javascript" src="https://www.googletagmanager.com/gtag/js?id=G-HLBNC861DJ" async> </script> 


    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"10.41"}
    h3,h4,h5,h6{--heading-prefix:"10.41"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->

<div id="project-nav">
  <a id="ihe-logo" no-external="true" href="http://profiles.ihe.net">
    <img height="71" alt="Visit the IHE website" src="assets/images/ihe-international.png"/>
  </a>
</div>
<div id="family-nav">
  <a id="family-logo" no-external="true" href="http://hl7.org/fhir"><img height="30" alt="Visit the FHIR website" src="assets/images/fhir-logo.png"/> </a>
</div>
<!--
<div id="hl7-search">
  <a id="hl7-search-lnk" no-external="true" href="searchform.html"><img alt="Search FHIR" src="assets/images/search.png"/></a>
</div>
-->
<div id="project-nav">
  
  
    <a id="project-logo" no-external="true" href="http://profiles.ihe.net/ITI/index.html"><img height="70" alt="Visit the ITI website" src="assets/images/ITI.png"/> </a>
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">Privacy Consent on FHIR (PCF)</span>
            <br/>
            <span style="display:inline-block;">1.0.0-comment - ballot



  <img alt="International flag" src="assets/images/001.svg" height="16" title="International"/>


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R5/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">PCF Home</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Volume 1
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="volume-1.html">Introduction</a>
      </li>
      <li>
        <a href="volume-1.html#actors-and-transactions">Actors and Transactions</a>
      </li>
      <li>
        <a href="volume-1.html#actor-options">Actor Options</a>
      </li>
      <li>
        <a href="volume-1.html#required-groupings">Required Groupings</a>
      </li>
      <li>
        <a href="volume-1.html#overview">Overview</a>
      </li>
      <li>
        <a href="volume-1.html#security-considerations">Security Considerations</a>
      </li>
      <li>
        <a href="volume-1.html#other-grouping">Cross-Profile Considerations</a>
      </li>
      <li>
        <a href="ch-P.html">Appendix P: Privacy Access Policies</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Volume 2
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="ITI-108.html">Access Consent [ITI-108]</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Volume 3
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="content.html">Consent Patterns</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Other
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="other.html">Changes to Other IHE Specifications</a>
      </li>
      <li>
        <a href="other.html#updates-to-iti-71">Updates to ITI-71</a>
      </li>
      <li>
        <a href="download.html">Download</a>
      </li>
      <li>
        <a href="testplan.html">Test Plan</a>
      </li>
    </ul>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>clinical codes that indicate HIV</b></li>

          <span style="float:right;">

            <a href="ValueSet-SlsSensitiveETHUD.change.history.html">&lt;prev</a> | 

            <a href="#bottom">bottom</a>

          | <a href="ValueSet-SlsSensitiveHIV-testing.html">next&gt;</a>

          </span>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">This page is part of the Privacy Consent on FHIR (PCF) (v1.0.0-comment: Publication Ballot 1) based on <a href="http://hl7.org/fhir/4.3.0">FHIR v4.3.0</a>. .  For a full list of available versions, see the <a href="https://profiles.ihe.net/ITI/PCF/history.html">Directory of published versions <img src="external.png" style="text-align: baseline"></a></p><!--EndReleaseHeader-->
  








<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>



  
    <li>
      <a href="ValueSet-SlsSensitiveHIV.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="ValueSet-SlsSensitiveHIV.json.html">JSON</a>
    </li>
  



  
    <li>
      <a href="ValueSet-SlsSensitiveHIV.change.history.html">History</a>
    </li>
  


</ul>

  <a name="root"> </a>
  <h2 id="root">ValueSet: clinical codes that indicate HIV

  </h2>
  <table class="colsi">

    <tr>
      <td colspan="4"><i>Official URL</i>: <span class="copy-text">https://profiles.ihe.net/ITI/PCF/ValueSet/SlsSensitiveHIV<button title="Click to copy URL" class="btn-copy" data-clipboard-text="https://profiles.ihe.net/ITI/PCF/ValueSet/SlsSensitiveHIV"/></span>
      </td>
      <td><i>Version</i>:
      <span class="copy-text">1.0.0-comment<button title="Click to copy versioned URL" class="btn-copy" data-clipboard-text="https://profiles.ihe.net/ITI/PCF/ValueSet/SlsSensitiveHIV|1.0.0-comment"/></span>
      </td>
    </tr>

    <tr>







      <td colspan="4">
        
          Active
          
            as of 2023-05-03
          
        
      </td>



      <td><i>Computable Name</i>: <span style="font-family: monospace;">SlsSensitiveHIV</span></td>
    </tr>




  </table>

<p>
<p>HIV/AIDS information</p>

<ul>
  <li><strong>SAMSHA C2S HIV/AIDS Information</strong>
    <ul>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.23 // HCPCS</li>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.24 // ICD9CM</li>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.25 // LOINC</li>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.26 // RXNORM</li>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.27 // SNOMED-CT</li>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.60 // CPT</li>
    </ul>
  </li>
  <li><strong>SAMSHA Test C2S HIV/AIDS Information Sensitivity</strong>
    <ul>
      <li>ValueSet 2.16.840.1.113762.1.4.1142.67 // SNOMEDCD</li>
    </ul>
  </li>
</ul>

</p>


  <p>
    <b>References</b>
  </p>
  
<p>This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)</p>


  <!-- insert intro if present -->
  



  <a name="definition"> </a>

<!-- Content Logical Definition heading in the fragment -->
  <h3>Logical Definition (CLD)</h3>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.23/expansion">C2S HIV/AIDS Information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.24/expansion">C2S HIV/AIDS Information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.25/expansion">C2S HIV/AIDS Information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.26/expansion">C2S HIV/AIDS Information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.27/expansion">C2S HIV/AIDS Information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.60/expansion">C2S HIV/AIDS information Sensitivity</a></li><li>Import all the codes that are contained in <a href="https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1142.67/expansion">Test C2S HIV/AIDS Information Sensitivity</a></li></ul></div>

  <p>&#160;</p>
  <a name="expansion"> </a>
  <h3 id="expansion">Expansion</h3>

  <div xmlns="http://www.w3.org/1999/xhtml"><p>This value set contains 162 concepts</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-0575F"> </a>  0575F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv rna control plan of care, documented (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3292F"> </a>  3292F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3490F"> </a>  3490F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>History of aids-defining condition (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3491F"> </a>  3491F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3492F"> </a>  3492F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>History of nadir cd4+ cell count &lt;350 cells/mm (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3493F"> </a>  3493F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>No history of nadir cd4+ cell count &lt;350 cells/mmand no history of aids-defining condition (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3494F"> </a>  3494F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell count &lt;200 cells/mm3 (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3495F"> </a>  3495F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell count 200 - 499 cells/mm3 (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3496F"> </a>  3496F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell count &gt;=500 cells/mm3 (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3497F"> </a>  3497F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell percentage &lt;15% (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3498F"> </a>  3498F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell percentage &gt;/=15% (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3500F"> </a>  3500F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3502F"> </a>  3502F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv rna viral load below limits of quantification (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3503F"> </a>  3503F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv rna viral load not below limits of quantification (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3510F"> </a>  3510F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3511F"> </a>  3511F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Chlamydia and gonorrhea screenings documented as performed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3512F"> </a>  3512F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Syphilis screening documented as performed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3513F"> </a>  3513F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hepatitis b screening documented as performed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3514F"> </a>  3514F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hepatitis c screening documented as performed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-3515F"> </a>  3515F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Patient has documented immunity to hepatitis c (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4149F"> </a>  4149F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4270F"> </a>  4270F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4271F"> </a>  4271F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4274F"> </a>  4274F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Influenza immunization administered or previously received (hiv) (p-esrd)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4276F"> </a>  4276F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Potent antiretroviral therapy prescribed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4279F"> </a>  4279F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4280F"> </a>  4280F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4290F"> </a>  4290F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Patient screened for injection drug use (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-4293F"> </a>  4293F</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Patient screened for high-risk sexual behavior (hiv)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-86689"> </a>  86689</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-86701"> </a>  86701</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis for antibody to HIV -1 virus</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-86702"> </a>  86702</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis for antibody to HIV-2 virus</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-86703"> </a>  86703</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis for antibody to HIV-1 and HIV-2 virus</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87389"> </a>  87389</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by immunoassay technique for HIV-1 antigen and HIV-1 and HIV-2 antibodies</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87390"> </a>  87390</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by immunoassay technique for HIV-1 antigen</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87391"> </a>  87391</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by immunoassay technique for HIV-2 antigen</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87534"> </a>  87534</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-1 virus, direct probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87535"> </a>  87535</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-1 virus, amplified probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87536"> </a>  87536</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-1 virus, quantification</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87537"> </a>  87537</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-2 virus, direct probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87538"> </a>  87538</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-2 virus, amplified probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87539"> </a>  87539</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Detection test by nucleic acid for HIV-2 virus, quantification</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87900"> </a>  87900</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Infectious agent drug susceptibility analysis</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87901"> </a>  87901</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis test by nucleic acid for HIV-1 virus</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87903"> </a>  87903</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis test by nucleic acid for HIV-1 virus, first through 10 drugs tested</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87904"> </a>  87904</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis test by nucleic acid for HIV-1 virus, each additional drug tested</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-87906"> </a>  87906</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Analysis test by nucleic acid for HIV-1 virus, other region</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-G0432"> </a>  G0432</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-G0433"> </a>  G0433</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-G0435"> </a>  G0435</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-hcpcs-S3645"> </a>  S3645</td><td>http://www.nlm.nih.gov/research/umls/hcpcs</td><td>Hiv-1 antibody testing of oral mucosal transudate</td></tr><tr><td style="white-space:nowrap"><a name="http---hl7.org-fhir-sid-icd-9-cm-136.3"> </a>  136.3</td><td>http://hl7.org/fhir/sid/icd-9-cm</td><td>Pneumocystosis</td></tr><tr><td style="white-space:nowrap"><a name="http---hl7.org-fhir-sid-icd-9-cm-176.9"> </a>  176.9</td><td>http://hl7.org/fhir/sid/icd-9-cm</td><td>Kaposi's sarcoma, unspecified site</td></tr><tr><td style="white-space:nowrap"><a name="http---hl7.org-fhir-sid-icd-9-cm-42"> </a>  42</td><td>http://hl7.org/fhir/sid/icd-9-cm</td><td>Operations on esophagus</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-10901-7"> </a>  <a href="https://loinc.org/10901-7/">10901-7</a></td><td>http://loinc.org</td><td>HIV 2 gp125 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-10902-5"> </a>  <a href="https://loinc.org/10902-5/">10902-5</a></td><td>http://loinc.org</td><td>HIV 2 gp36 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-11078-3"> </a>  <a href="https://loinc.org/11078-3/">11078-3</a></td><td>http://loinc.org</td><td>HIV 2 gp80 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-11079-1"> </a>  <a href="https://loinc.org/11079-1/">11079-1</a></td><td>http://loinc.org</td><td>HIV 2 p26 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-11080-9"> </a>  <a href="https://loinc.org/11080-9/">11080-9</a></td><td>http://loinc.org</td><td>HIV 2 p53 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-11081-7"> </a>  <a href="https://loinc.org/11081-7/">11081-7</a></td><td>http://loinc.org</td><td>HIV 2 p56 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-11082-5"> </a>  <a href="https://loinc.org/11082-5/">11082-5</a></td><td>http://loinc.org</td><td>HIV 2 p68 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-13920-4"> </a>  <a href="https://loinc.org/13920-4/">13920-4</a></td><td>http://loinc.org</td><td>HIV 2 p41 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21334-8"> </a>  <a href="https://loinc.org/21334-8/">21334-8</a></td><td>http://loinc.org</td><td>HIV 2 gp105 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21335-5"> </a>  <a href="https://loinc.org/21335-5/">21335-5</a></td><td>http://loinc.org</td><td>HIV 2 gp120 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21336-3"> </a>  <a href="https://loinc.org/21336-3/">21336-3</a></td><td>http://loinc.org</td><td>HIV 2 gp15 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21337-1"> </a>  <a href="https://loinc.org/21337-1/">21337-1</a></td><td>http://loinc.org</td><td>HIV 2 gp34 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21338-9"> </a>  <a href="https://loinc.org/21338-9/">21338-9</a></td><td>http://loinc.org</td><td>HIV 2 p31 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21339-7"> </a>  <a href="https://loinc.org/21339-7/">21339-7</a></td><td>http://loinc.org</td><td>HIV 2 p55 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-21340-5"> </a>  <a href="https://loinc.org/21340-5/">21340-5</a></td><td>http://loinc.org</td><td>HIV 2 p58 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-22358-6"> </a>  <a href="https://loinc.org/22358-6/">22358-6</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Units/volume] in Serum</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-25841-8"> </a>  <a href="https://loinc.org/25841-8/">25841-8</a></td><td>http://loinc.org</td><td>HIV 2 proviral DNA [Presence] in Blood by NAA with probe detection</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-25842-6"> </a>  <a href="https://loinc.org/25842-6/">25842-6</a></td><td>http://loinc.org</td><td>HIV 2 proviral DNA [Presence] in Specimen by NAA with probe detection</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-30361-0"> </a>  <a href="https://loinc.org/30361-0/">30361-0</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-31073-0"> </a>  <a href="https://loinc.org/31073-0/">31073-0</a></td><td>http://loinc.org</td><td>HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-33806-1"> </a>  <a href="https://loinc.org/33806-1/">33806-1</a></td><td>http://loinc.org</td><td>HIV 2 IgG Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-33807-9"> </a>  <a href="https://loinc.org/33807-9/">33807-9</a></td><td>http://loinc.org</td><td>HIV 2 IgG Ab [Presence] in Serum</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-34699-9"> </a>  <a href="https://loinc.org/34699-9/">34699-9</a></td><td>http://loinc.org</td><td>HIV 2 proviral DNA [Presence] in Serum or Plasma by NAA with probe detection</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-42768-2"> </a>  <a href="https://loinc.org/42768-2/">42768-2</a></td><td>http://loinc.org</td><td>HIV 1 and 2 Ab [Interpretation] in Serum Narrative</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-43185-8"> </a>  <a href="https://loinc.org/43185-8/">43185-8</a></td><td>http://loinc.org</td><td>HIV 1 and 2 Ab band pattern [Interpretation] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-45212-8"> </a>  <a href="https://loinc.org/45212-8/">45212-8</a></td><td>http://loinc.org</td><td>HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-47029-4"> </a>  <a href="https://loinc.org/47029-4/">47029-4</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-51786-2"> </a>  <a href="https://loinc.org/51786-2/">51786-2</a></td><td>http://loinc.org</td><td>HIV 2 Ab Signal/Cutoff in Serum or Plasma by Immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-5224-1"> </a>  <a href="https://loinc.org/5224-1/">5224-1</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-5225-8"> </a>  <a href="https://loinc.org/5225-8/">5225-8</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-56888-1"> </a>  <a href="https://loinc.org/56888-1/">56888-1</a></td><td>http://loinc.org</td><td>HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-57976-3"> </a>  <a href="https://loinc.org/57976-3/">57976-3</a></td><td>http://loinc.org</td><td>HIV 2 gp140 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-57977-1"> </a>  <a href="https://loinc.org/57977-1/">57977-1</a></td><td>http://loinc.org</td><td>HIV 2 p16 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-57978-9"> </a>  <a href="https://loinc.org/57978-9/">57978-9</a></td><td>http://loinc.org</td><td>HIV 2 p34 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-58900-2"> </a>  <a href="https://loinc.org/58900-2/">58900-2</a></td><td>http://loinc.org</td><td>HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-62456-9"> </a>  <a href="https://loinc.org/62456-9/">62456-9</a></td><td>http://loinc.org</td><td>HIV 2 p15 Ab [Presence] in Serum by Immunoblot</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-6429-5"> </a>  <a href="https://loinc.org/6429-5/">6429-5</a></td><td>http://loinc.org</td><td>HIV identified in Blood by Organism specific culture</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-6430-3"> </a>  <a href="https://loinc.org/6430-3/">6430-3</a></td><td>http://loinc.org</td><td>HIV identified in Semen by Organism specific culture</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-6431-1"> </a>  <a href="https://loinc.org/6431-1/">6431-1</a></td><td>http://loinc.org</td><td>HIV identified in Specimen by Organism specific culture</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-69353-1"> </a>  <a href="https://loinc.org/69353-1/">69353-1</a></td><td>http://loinc.org</td><td>HIV 2 RNA [Presence] in Serum or Plasma by NAA with probe detection</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-69354-9"> </a>  <a href="https://loinc.org/69354-9/">69354-9</a></td><td>http://loinc.org</td><td>HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-69668-2"> </a>  <a href="https://loinc.org/69668-2/">69668-2</a></td><td>http://loinc.org</td><td>HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-7919-4"> </a>  <a href="https://loinc.org/7919-4/">7919-4</a></td><td>http://loinc.org</td><td>HIV 2 Ab [Presence] in Serum</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-9836-8"> </a>  <a href="https://loinc.org/9836-8/">9836-8</a></td><td>http://loinc.org</td><td>HIV proviral DNA [Presence] in Blood by Probe with amplification</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP14307-0"> </a>  <a href="https://loinc.org/LP14307-0/">LP14307-0</a></td><td>http://loinc.org</td><td>HIV 1</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP16715-2"> </a>  <a href="https://loinc.org/LP16715-2/">LP16715-2</a></td><td>http://loinc.org</td><td>HIV 1+2</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP16716-0"> </a>  <a href="https://loinc.org/LP16716-0/">LP16716-0</a></td><td>http://loinc.org</td><td>HIV 2</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP29063-2"> </a>  <a href="https://loinc.org/LP29063-2/">LP29063-2</a></td><td>http://loinc.org</td><td>HIV reverse transcriptase gene</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP30901-0"> </a>  <a href="https://loinc.org/LP30901-0/">LP30901-0</a></td><td>http://loinc.org</td><td>HIV protease gene</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP32723-6"> </a>  <a href="https://loinc.org/LP32723-6/">LP32723-6</a></td><td>http://loinc.org</td><td>HIV reverse transcriptase+protease gene</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP36650-7"> </a>  <a href="https://loinc.org/LP36650-7/">LP36650-7</a></td><td>http://loinc.org</td><td>HIV 1 &amp; 2</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP36876-8"> </a>  <a href="https://loinc.org/LP36876-8/">LP36876-8</a></td><td>http://loinc.org</td><td>HIV nucleoside reverse transcriptase gene</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP36877-6"> </a>  <a href="https://loinc.org/LP36877-6/">LP36877-6</a></td><td>http://loinc.org</td><td>HIV nonnucleoside reverse transcriptase gene</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP38420-3"> </a>  <a href="https://loinc.org/LP38420-3/">LP38420-3</a></td><td>http://loinc.org</td><td>HIV identified</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP38459-1"> </a>  <a href="https://loinc.org/LP38459-1/">LP38459-1</a></td><td>http://loinc.org</td><td>HIV 1+2 Ab</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP38463-3"> </a>  <a href="https://loinc.org/LP38463-3/">LP38463-3</a></td><td>http://loinc.org</td><td>HIV 2 Ab</td></tr><tr><td style="white-space:nowrap"><a name="http---loinc.org-LP62411-1"> </a>  <a href="https://loinc.org/LP62411-1/">LP62411-1</a></td><td>http://loinc.org</td><td>HIV 1+O+2 Ab</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-rxnorm-152535"> </a>  152535</td><td>http://www.nlm.nih.gov/research/umls/rxnorm</td><td>Zovirax</td></tr><tr><td style="white-space:nowrap"><a name="http---www.nlm.nih.gov-research-umls-rxnorm-281"> </a>  281</td><td>http://www.nlm.nih.gov/research/umls/rxnorm</td><td>acyclovir</td></tr><tr><td style="white-space:nowrap"><a name="http---snomed.info-sct-111880001"> </a>  <a href="http://snomed.info/id/111880001">111880001</a></td><td>http://snomed.info/sct</td><td>Acute human immunodeficiency virus infection (disorder)</td></tr><tr><td style="white-space:nowrap"><a name="http---snomed.info-sct-420721002"> </a>  <a href="http://snomed.info/id/420721002">420721002</a></td><td>http://snomed.info/sct</td><td>Acquired immunodeficiency syndrome-associated disorder (disorder)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-0575F"> </a>  0575F</td><td>http://www.ama-assn.org/go/cpt</td><td>HIV RNA control plan of care, documented (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3292F"> </a>  3292F</td><td>http://www.ama-assn.org/go/cpt</td><td>HIV testing ordered or documented and reviewed during the first or second prenatal visit (Pre-Cr)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3490F"> </a>  3490F</td><td>http://www.ama-assn.org/go/cpt</td><td>History of AIDS-defining condition (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3491F"> </a>  3491F</td><td>http://www.ama-assn.org/go/cpt</td><td>HIV indeterminate (infants of undetermined HIV status born of HIV-infected mothers) (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3492F"> </a>  3492F</td><td>http://www.ama-assn.org/go/cpt</td><td>History of nadir CD4+ cell count &lt;350 cells/mm3 (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3493F"> </a>  3493F</td><td>http://www.ama-assn.org/go/cpt</td><td>No history of nadir CD4+ cell count &lt;350 cells/mm3 and no history of AIDS-defining condition (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3494F"> </a>  3494F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell count &lt;200 cells/mm3 (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3495F"> </a>  3495F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell count 200 - 499 cells/mm3 (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3496F"> </a>  3496F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell count &gt;/=500 cells/mm3 (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3497F"> </a>  3497F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell percentage &lt;15% (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3498F"> </a>  3498F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell percentage &gt;/=15% (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3500F"> </a>  3500F</td><td>http://www.ama-assn.org/go/cpt</td><td>CD4+ cell count or CD4+ cell percentage documented as performed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3502F"> </a>  3502F</td><td>http://www.ama-assn.org/go/cpt</td><td>HIV RNA viral load below limits of quantification (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3503F"> </a>  3503F</td><td>http://www.ama-assn.org/go/cpt</td><td>HIV RNA viral load not below limits of quantification (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3510F"> </a>  3510F</td><td>http://www.ama-assn.org/go/cpt</td><td>Documentation that tuberculosis (TB) screening test performed and results interpreted (HIV) (IBD)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3511F"> </a>  3511F</td><td>http://www.ama-assn.org/go/cpt</td><td>Chlamydia and gonorrhea screenings documented as performed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3512F"> </a>  3512F</td><td>http://www.ama-assn.org/go/cpt</td><td>Syphilis screening documented as performed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3513F"> </a>  3513F</td><td>http://www.ama-assn.org/go/cpt</td><td>Hepatitis B screening documented as performed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3514F"> </a>  3514F</td><td>http://www.ama-assn.org/go/cpt</td><td>Hepatitis C screening documented as performed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-3515F"> </a>  3515F</td><td>http://www.ama-assn.org/go/cpt</td><td>Patient has documented immunity to Hepatitis C (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4149F"> </a>  4149F</td><td>http://www.ama-assn.org/go/cpt</td><td>Hepatitis B vaccine injection administered or previously received (HEP-C, HIV) (IBD)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4270F"> </a>  4270F</td><td>http://www.ama-assn.org/go/cpt</td><td>Patient receiving potent antiretroviral therapy for 6 months or longer (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4271F"> </a>  4271F</td><td>http://www.ama-assn.org/go/cpt</td><td>Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4274F"> </a>  4274F</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza immunization administered or previously received (HIV) (P-ESRD)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4276F"> </a>  4276F</td><td>http://www.ama-assn.org/go/cpt</td><td>Potent antiretroviral therapy prescribed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4279F"> </a>  4279F</td><td>http://www.ama-assn.org/go/cpt</td><td>Pneumocystis jiroveci pneumonia prophylaxis prescribed (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4280F"> </a>  4280F</td><td>http://www.ama-assn.org/go/cpt</td><td>Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low CD4+ cell count or percentage (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4290F"> </a>  4290F</td><td>http://www.ama-assn.org/go/cpt</td><td>Patient screened for injection drug use (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-4293F"> </a>  4293F</td><td>http://www.ama-assn.org/go/cpt</td><td>Patient screened for high-risk sexual behavior (HIV)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-86689"> </a>  86689</td><td>http://www.ama-assn.org/go/cpt</td><td>Antibody; HTLV or HIV antibody, confirmatory test (eg, Western Blot)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-86701"> </a>  86701</td><td>http://www.ama-assn.org/go/cpt</td><td>Antibody; HIV-1</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-86702"> </a>  86702</td><td>http://www.ama-assn.org/go/cpt</td><td>Antibody; HIV-2</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-86703"> </a>  86703</td><td>http://www.ama-assn.org/go/cpt</td><td>Antibody; HIV-1 and HIV-2, single result</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87389"> </a>  87389</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87390"> </a>  87390</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87391"> </a>  87391</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-2</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87534"> </a>  87534</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, direct probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87535"> </a>  87535</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, amplified probe technique, includes reverse transcription when performed</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87536"> </a>  87536</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87537"> </a>  87537</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, direct probe technique</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87538"> </a>  87538</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, amplified probe technique, includes reverse transcription when performed</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87539"> </a>  87539</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification, includes reverse transcription when performed</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87900"> </a>  87900</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent drug susceptibility phenotype prediction using regularly updated genotypic bioinformatics</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87901"> </a>  87901</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, reverse transcriptase and protease regions</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87903"> </a>  87903</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; first through 10 drugs tested</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87904"> </a>  87904</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; each additional drug tested (List separately in addition to code for primary procedure)</td></tr><tr><td style="white-space:nowrap"><a name="http---www.ama-assn.org-go-cpt-87906"> </a>  87906</td><td>http://www.ama-assn.org/go/cpt</td><td>Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, other region (eg, integrase, fusion)</td></tr></table></div>

  <hr/>
  <p>
    Explanation of the columns that may appear on this page:
  </p>
  <table class="grid">
    <tr>
      <td>Level</td>
      <td>A few code lists that FHIR defines are hierarchical - each code is assigned a level.
          In this scheme, some codes are under other codes, and imply that the code they are under also applies</td>
    </tr>
    <tr>
      <td>System</td>
      <td>The source of the definition of the code (when the value set draws in codes defined elsewhere)</td>
    </tr>
    <tr>
      <td>Code</td>
      <td>The code (used as the code in the resource instance)</td>
    </tr>
    <tr>
      <td>Display</td>
      <td>The display (used in the <i>display</i> element of a <a href="http://hl7.org/fhir/R5/datatypes.html#Coding">Coding</a>). If there is no display, implementers should not simply display the code, but map the concept into their application</td>
    </tr>
    <tr>
      <td>Definition</td>
      <td>An explanation of the meaning of the concept</td>
    </tr>
    <tr>
      <td>Comments</td>
      <td>Additional notes about how to use the code</td>
    </tr>
  </table>

  

  <!-- insert notes if present -->
  



  <div><hr/><p><b>History</b></p><table class="grid"><tr><td><b>Date</b></td><td><b>Action</b></td><td><b><a href="http://terminology.hl7.org/4.0.0/CodeSystem-provenance-participant-type.html#provenance-participant-type-author">Author</a></b></td><td><b><a href="http://terminology.hl7.org/4.0.0/CodeSystem-provenance-participant-type.html#provenance-participant-type-verifier">Verifier</a></b></td><td><b>Comment</b></td></tr><tr><td><a href="Provenance-SlsSensitive-update-history.html">2023-01-31</a></td><td><a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-DataOperation.html#v3-DataOperation-UPDATE">revise</a></td><td>John Moehrke</td><td/><td>Administrative touchup to add history</td></tr><tr><td><a href="Provenance-SlsSensitive-initial-history.html">2022-07-27</a></td><td><a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-DataOperation.html#v3-DataOperation-CREATE">create</a></td><td>John Moehrke</td><td>John F. Moehrke</td><td>Initial ValueSet as per the C2S layout</td></tr></table></div>

</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div style="background-color:var(--footer-nav-bg-color)">
        <table style="width:100%">
          <tbody>
            <tr>
              <td style="text-align:left">&#xA0;

                <a href="ValueSet-SlsSensitiveETHUD.change.history.html">&lt;prev</a>

              </td>
              <td style="text-align:center">
                <a href="#top">top</a>
              </td>
              <td style="text-align:right">&#xA0;

                <a href="ValueSet-SlsSensitiveHIV-testing.html">next&gt;</a>

              </td>
            </tr>
          </tbody>
        </table>
      </div>

      <div class="inner-wrapper">
        <p>
          IG &#169; 2023+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.ihe.net/ihe_domains/it_infrastructure/">IHE IT Infrastructure Technical Committee</a>.  Package ihe.iti.pcf#1.0.0-comment based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R5/">FHIR 4.3.0</a>. Generated <span title="Wed, May 3, 2023 08:22-0500">2023-05-03</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                  | <a style="color: var(--footer-hyperlink-text-color)" target="_blank" href="https://github.com/IHE/ITI.PCF/issues/new/choose">New Issue</a> | <a style="color: var(--footer-hyperlink-text-color)" target="_blank" href="https://github.com/IHE/ITI.PCF/issues">Issues</a>
                
                 <a style="color: var(--footer-hyperlink-text-color)" target="_blank" href="https://profiles.ihe.net/ITI/PCF/history.html">Version History</a></a> |
                 <a style="color: var(--footer-hyperlink-text-color)" rel="license" href="https://profiles.ihe.net/GeneralIntro/ch-9.html"><img style="border-style: none;" alt="CC0" src="assets/images/cc-by.png" height="17"/></a> |
                <!-- <a style="color: var(--footer-hyperlink-text-color)" href="searchform.html">Search</a> | -->
                 <a style="color: var(--footer-hyperlink-text-color)" target="_blank" href="https://www.ihe.net/resources/public_comment/">Propose a change<img alt="external" style="vertical-align: baseline" src="external.png"/></a>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());
  gtag('config', 'G-HLBNC861DJ');
</script>

          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
<!-- feedback form - Google forms -->
<!-- v0.1, 2021-01-09 -->


  
    
  


  
    
  



<!-- / feedback form  -->

  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

